Grifols SA (GIFLF) balance sheet

GIFLFOTCPharmaceutical PreparationsAlso trades as GIFOF, GIKLY, GRFS

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 17, 2026Score 9/30

$10.55+0.00 (0.00%)

Close on Oct 19, 2026Market cap $3.63BP/E 8.0Yield –

Grifols SA balance sheet

Annual Quarterly

EUR USD

Millions of USD, except per-share data. Shares in millions.

Line item	Q4 2025 2025-12-31	Q4 2024 2024-12-31	Q4 2023 2023-12-31	Q4 2022 2022-12-31	Q4 2021 2021-12-31	Q4 2020 2020-12-31	Q4 2019 2019-12-31	Q4 2018 2018-12-31	Q4 2017 2017-12-31	Q4 2016 2016-12-31	Q4 2015 2015-12-31	Q4 2014 2014-12-31
Cash & Equivalents	968	1,014	585	587	3,029	709	833	1,184	1,066	944	1,241	1,306
Cash & Short-Term Investments	968	1,014	585	587	3,029	709	833	1,184	1,066	944	1,241	1,306
Receivables	902	865	849	791	566	636	551	463	465	563	–	–
Inventory	3,868	3,685	3,852	3,462	2,557	2,449	2,630	2,233	1,959	1,734	–	–
Other Current Assets	76	75	82	88	73	63	65	49	39	51	–	–
Total Current Assets	5,955	5,929	6,782	5,018	6,237	3,871	6,020	3,990	3,541	3,295	–	–
Property, Plant & Equipment	3,662	3,459	3,592	3,533	2,883	2,842	2,425	2,236	2,116	1,910	1,786	–
Operating Lease Right-of-Use Assets	1,094	1,002	1,046	1,050	901	830	790	–	–	–	–	–
Goodwill	8,019	7,663	7,524	7,501	7,050	6,521	6,183	5,968	5,519	3,845	3,836	–
Intangible Assets	3,202	3,029	3,133	3,155	1,853	1,905	1,609	1,587	1,526	1,261	1,261	–
Deferred Tax Assets	488	354	332	187	173	183	138	–	–	–	–	–
Other Long-Term Assets	–	142	150	133	–	–	–	–	–	–	–	–
Total Assets	23,134	22,156	23,221	22,711	21,769	18,681	17,450	14,294	13,128	10,689	10,427	–
Accounts Payable	1,312	1,162	1,074	983	889	913	846	829	687	646	–	–
Current Debt	0.19	0.33	746	481	145	207	209	177	40	110	–	–
Current Portion of Leases	133	121	118	110	55	52	50	–	–	–	–	–
Current Income Taxes Payable	29	63	16	17	5.11	4.26	6.70	2.20	8.07	8.40	–	–
Other Current Liabilities	369	329	313	260	248	187	222	194	174	148	–	–
Total Current Liabilities	2,369	2,232	2,572	2,160	3,932	1,633	1,534	1,440	1,176	1,131	–	–
Long-Term Debt	2,534	2,420	4,037	3,843	4,051	4,030	3,931	5,741	6,034	–	–	–
Long-Term Leases	1,137	1,061	1,111	978	934	845	782	–	–	–	–	–
Operating Lease Liabilities	1,270	1,182	1,229	1,088	989	897	832	–	–	–	–	–
Deferred Tax Liabilities	1,010	1,048	1,094	1,107	718	681	–	–	–	–	–	–
Other Long-Term Liabilities	3.52	1.04	–	0.02	0.38	20	1.10	1.49	–	–	–	–
Total Liabilities	14,211	13,248	14,910	14,179	13,487	10,462	9,764	8,913	8,760	6,755	6,842	–
Total Debt	2,534	2,420	4,783	4,324	4,196	4,237	4,140	5,918	6,074	110	–	–
Common Stock	140	124	132	128	135	146	134	137	144	126	–	–
Additional Paid-In Capital	1,069	943	1,007	974	1,031	1,114	1,022	1,043	1,095	961	–	–
Treasury Stock	-154	-140	-169	-174	-186	-53	-56	-64	-75	-73	–	–
Shareholders' Equity	6,186	6,089	5,938	6,043	6,252	6,248	5,414	4,841	4,363	3,927	–	–
Noncontrolling Interest	2,737	2,819	2,373	2,490	2,030	1,971	2,272	540	5.87	6.86	–	–
Total Equity	8,923	8,908	8,311	8,534	7,763	8,219	7,686	5,380	4,369	3,934	3,585	3,222
Total Liabilities & Equity	23,134	22,156	23,221	22,711	21,769	18,681	17,450	14,294	13,128	10,689	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin: 38.0%
Operating margin: 16.5%
Net margin: 5.3%
Return on equity, FY2025: 7.2%

Financial strength

Current ratio: 2.51
Debt to equity: 0.41
Debt to assets: 11.0%
Cash to current liabilities: 40.9%

Valuation

P/E ratio: 8.0
Price to sales: 0.43
Price to book: 0.62
Dividend yield: –

See a number that looks wrong?